David J. Mazzo, Director at AVANIR PHARMACEUTICALS (AVN), bought 7,435 shares at $15.59 ($16K) on 2006-02-14, disclosed to the SEC on 2006-02-15.
Open-market purchase of $16k AVN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 6,435 | $0 | 0.0% |
| 2 | $15.59 | 1,000 | $16K | 100.0% |
| Total | $2.10 avg | 7,435 | $16K | 100% |